Evidence map›Paper›PMID 38895272›Full record

ArticlebioRxiv : the preprint server for biology2025

A mathematical model for ketosis-prone diabetes suggests the existence of multiple pancreatic β-cell inactivation mechanisms.

Sean A Ridout, Priyathama Vellanki, Ilya Nemenman

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Sean A RidoutDepartment of Physics, Emory University, Atlanta, GA, USA.ORCID 0000-0003-2387-8361
Priyathama VellankiDepartment of Internal Medicine, Division of Endocrinology, Emory University School of Medicine, Emory University, Atlanta, GA, USA.
Ilya NemenmanDepartment of Physics, Emory University, Atlanta, GA, USA.

Funding

Pilot & Feasibility CoreP30DK125013 · NIDDK · EMORY UNIVERSITY · PI Arlene A Stecenko · 2020 to 2026
$6.7M
Mechanisms of ketosis and near-normoglycemia remission in obese African Americans with ketosis-prone diabetesR03DK129627 · NIDDK · EMORY UNIVERSITY · PI VELLANKI, PRIYATHAMA · 2022 to 2023
$235k
NIDDK NIH HHS P30 DK125013NIDDK NIH HHS R03 DK129627
6 · The paper itself

Abstract

Ketosis-prone diabetes mellitus (KPD) is a subtype of type 2 diabetes, which presents much like type 1 diabetes, with dramatic hyperglycemia and ketoacidosis. Although KPD patients are initially insulin-dependent, after a few months of insulin treatment, roughly 70% undergo near-normoglycemia remission and can maintain blood glucose without insulin, as in early type 2 diabetes or prediabetes. Here, we propose that these phenomena can be explained by the existence of a fast, reversible glucotoxicity process, which may exist in all people but be more pronounced in those susceptible to KPD. We develop a simple mathematical model of the pathogenesis of KPD, which incorporates this assumption, and show that it reproduces the phenomenology of KPD, including variations in the ability for patients to achieve and sustain remission. These results suggest that a variation of our model may be able to quantitatively describe variations in the course of remission among individuals with KPD.

Identifiers

PMID38895272
PMCPMC11185683

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.